Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Rhabdomyosarcoma Fusion Gene Related Circular RNA Molecular Marker and Its Application

A technology of rhabdomyosarcoma and molecular markers, applied in the field of biomedical testing, can solve problems such as the specific mechanism to be elucidated, and achieve high detection rate and sensitivity

Active Publication Date: 2022-03-15
BEIJING CHAOYANG HOSPITAL CAPITAL MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above studies have shown that F-circRNA produced by chromosomal translocation can lead to the development of tumors, but the specific mechanism remains to be elucidated
So far, there have been no reports of rhabdomyosarcoma-specific chromosomal translocations producing fusion gene-associated F-circRNAs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rhabdomyosarcoma Fusion Gene Related Circular RNA Molecular Marker and Its Application
  • Rhabdomyosarcoma Fusion Gene Related Circular RNA Molecular Marker and Its Application
  • Rhabdomyosarcoma Fusion Gene Related Circular RNA Molecular Marker and Its Application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] This embodiment provides a molecular marker of rhabdomyosarcoma fusion gene-related circular RNA, said marker is F-circP3F, and the nucleotide sequence of the marker is shown in SEQ ID No.1. The molecular markers can be used in the diagnosis of rhabdomyosarcoma products.

[0035]The design idea of ​​this application is: when the applicant uses RT-PCR technology to amplify the fusion gene PAX3-FOXO1 and its related circ RNA in the acinar RMS, it is speculated that PAX3-FOXO1 may be composed of intron 4 and intron 4 of PAX3 during the transcription process. Intron 2 of FOXO1 is complementary paired to form a circular lariat, and the intron is back-spliced ​​to form a circular RNA associated with the fusion gene. Then, by optimizing the primer design and linear RNA digestion, a positive target fragment was amplified in the acinar RMS cell line using divergent primers, and it was confirmed as a fusion by Sanger sequencing the PCR product and comparing it with the NCBI datab...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a molecular marker of a rhabdomyosarcoma fusion gene-related circular RNA and an application thereof. The molecular marker of the rhabdomyosarcoma PAX3-FOXO1 fusion gene-related circular RNA is F-circP3F, and the nuclear marker of the molecular marker The nucleotide sequence is shown in SEQ ID No.1. The F-circP3F provided by the present invention has high sensitivity and specificity for alveolar rhabdomyosarcoma, and can be used as a novel molecular marker for the detection of rhabdomyosarcoma. By optimizing the primers and RT-PCR reaction system, this method can successfully amplify F-circP3F in the case of low RNA content in alveolar rhabdomyosarcoma cells and tissues, with strong sensitivity and specificity; F-circP3F can not only be applied It can be used in the diagnosis, classification and prognosis evaluation of rhabdomyosarcoma, and may provide a new way for the study of epigenetic regulation and molecular diagnosis and treatment strategies of rhabdomyosarcoma.

Description

technical field [0001] The invention relates to the technical field of biomedical testing, in particular to a molecular marker of rhabdomyosarcoma fusion gene-related circular RNA and its application. Background technique [0002] Rhabdomyosarcoma (rhabdomyosarcoma, RMS) is the most common soft tissue malignancy in children and adolescents, accounting for about 50% of all soft tissue malignancies in children. According to clinical and histomorphological characteristics, it can be divided into four types: embryonal RMS (ERMS), alveolar RMS (ARMS), spindle cell RMS (SRMS) and pleomorphic RMS (PRMS). main types. They differ not only in age of onset, location, tissue morphology, etc., but also in treatment and prognosis. So far, studies have found that the occurrence and development of rhabdomyosarcoma (RMS) are closely related to molecular genetic changes such as the formation of chromosomal translocation fusion genes. The specific information on chromosomal translocations an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886C12N15/113C12N15/11
CPCC12Q1/6886C12N15/113C12Q2600/158C12Q2600/178C12Q2600/112C12N2310/532
Inventor 李锋宋凌勰宋阳光贾兴元文豪张莹郭丹丹缪冉
Owner BEIJING CHAOYANG HOSPITAL CAPITAL MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com